GRIFOLS | GRF - Gross Profit On Sales


GRIFOLS reported EUR686.84M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Alcon AG USD 1.69B 175M Mar/2026
Almirall EUR 429.87M 180.02M Dec/2025
Amadeus IT EUR 754.9M 225.7M Mar/2026
Amarin USD 23.17M 961K Dec/2025
argenx SE USD 1.18B 40.98M Mar/2026
AstraZeneca USD 12.61B 225M Mar/2026
Bayer EUR 6.94B 1.58B Dec/2025
Cie Automotive EUR 805.54M 79.61M Dec/2024
Demant DKK 8.82B 277M Dec/2025
Ence Energia y Celulosa EUR 64M 117.3M Mar/2026
Essilor EUR 8.3B 547M Dec/2025
Ferrovial EUR 4.27B 498M Dec/2024
Fresenius EUR 1.51B 214M Dec/2025
Fresenius Medical Care EUR 1.18B 210M Mar/2026
Genmab DKK 977M 13M Dec/2025
GlaxoSmithKline GBP 5.75B 429M Mar/2026
GRIFOLS EUR 686.84M 56.95M Dec/2025
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Inditex EUR 5.36B 1.05B Mar/2026
Lakefront Biotherapeutics EUR 1.68M 898.68M Mar/2026
Merck EUR 3.07B 104M Mar/2026
Novartis USD 10.07B 184M Mar/2026
Philips EUR 1.77B 522M Mar/2026
Roche Holding CHF 22.09B 10.04B Dec/2025
Sanofi EUR 8.45B 1.31B Dec/2025
Smith & Nephew USD 2.09B 117M Dec/2025
UCB EUR 3.19B 621M Dec/2025
Viscofan EUR 112.29M 226K Mar/2026